Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 2CNS 2Thoracic 1NET 1Head & Neck 1Dermatologic 1Breast 1

Conditions

Lung Neoplasms 43Carcinoma, Non-Small-Cell Lung 38Melanoma 9Small Cell Lung Carcinoma 7Neoplasm Metastasis 7Neoplasms 5Adenocarcinoma of Lung 5Squamous Cell Carcinoma of Head and Neck 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Esophageal Neoplasms 3Endometrial Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2Skin Neoplasms 2Sarcoma, Kaposi 2Salivary Gland Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Kidney Neoplasms 2Head and Neck Neoplasms 2HIV Infections 2Colorectal Neoplasms 2Carcinoma, Transitional Cell 2Anus Neoplasms 2Vulvar Neoplasms 1Uveal Melanoma 1

Interventions

Fluorodeoxyglucose F18 2fludarabine phosphate 1Specimen Handling 1Magnetic Resonance Spectroscopy 1Interleukin-13 1Cyclophosphamide 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Paraganglioma × Biopsy × Thoracic × Clear all
NCT04119024 2026-03-17

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Stanford University

Phase 1 Recruiting
18 enrolled
BreastCNSDermatologicEndocrineHead & NeckNETThoracic

Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Adenoma, Islet Cell, Melanoma, Neoplasm Metastasis, Paraganglioma, Pheochromocytoma, Thyroid Neoplasms, Adrenocortical Carcinoma, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡